Correlation Between Landos Biopharma and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Landos Biopharma and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Landos Biopharma and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Landos Biopharma and Transcode Therapeutics, you can compare the effects of market volatilities on Landos Biopharma and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Landos Biopharma with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Landos Biopharma and Transcode Therapeutics.
Diversification Opportunities for Landos Biopharma and Transcode Therapeutics
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Landos and Transcode is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Landos Biopharma and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Landos Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Landos Biopharma are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Landos Biopharma i.e., Landos Biopharma and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Landos Biopharma and Transcode Therapeutics
Given the investment horizon of 90 days Landos Biopharma is expected to generate 0.24 times more return on investment than Transcode Therapeutics. However, Landos Biopharma is 4.08 times less risky than Transcode Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 284.00 in Landos Biopharma on August 24, 2024 and sell it today you would earn a total of 118.00 from holding Landos Biopharma or generate 41.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 18.8% |
| Values | Daily Returns |
Landos Biopharma vs. Transcode Therapeutics
Performance |
| Timeline |
| Landos Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Transcode Therapeutics |
Landos Biopharma and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Landos Biopharma and Transcode Therapeutics
The main advantage of trading using opposite Landos Biopharma and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Landos Biopharma position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| Landos Biopharma vs. Apollomics Class A | Landos Biopharma vs. Cardio Diagnostics Holdings | Landos Biopharma vs. Transcode Therapeutics | Landos Biopharma vs. Xenetic Biosciences |
| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |